| pharmaceuticals |
Cdet ± µ
mg/L |
Recovery,
% |
RSD intra-day
% |
RSD inter-days
% |
| System I |
|
Diphergan |
10.04 ± 0.05 |
100.4 |
0.52 |
1.42 |
| 20.07 ± 0.32 |
100.3 |
1.28 |
1.32 |
| 29.98 ± 0.13 |
99.93 |
0.72 |
0.95 |
| Thioridazin |
10.02 ± 0.13 |
100.2 |
1.15 |
1.11 |
| 19.95 ± 0.10 |
99.75 |
0.67 |
0.83 |
| 29.93 ± 0.12 |
99.77 |
0.34 |
0.56 |
| Fenactil |
9.91 ± 0.05 |
99.10 |
0.74 |
0.98 |
| 19.89 ± 0.08 |
99.45 |
0.69 |
0.57 |
| 29.94 ± 0.14 |
99.80 |
0.53 |
0.43 |
| System II |
| Diphergan |
10.12 ± 0.08 |
101.2 |
0.58 |
0.68 |
| 20.07 ± 0.09 |
100.3 |
0.51 |
0.49 |
| 30.02 ± 0.16 |
100.1 |
0.49 |
0.75 |
| Thioridazin |
10.13 ± 0.07 |
101.3 |
0.67 |
0.92 |
| 20.17 ± 0.07 |
100.8 |
0.38 |
0.67 |
| 30.20 ± 0.10 |
100.7 |
0.34 |
0.36 |
| Fenactil |
10.10 ± 0.05 |
101.0 |
0.52 |
0.46 |
| 20.16 ± 0.08 |
100.8 |
0.73 |
0.95 |
| 30.22 ± 0.07 |
100.7 |
0.46 |
0.42 |
| System III |
| Diphergan |
9.87 ± 0.07 |
98.70 |
0.68 |
0.79 |
| 19.68 ± 0.13 |
98.40 |
0.70 |
0.82 |
| 29.58 ± 0.13 |
98.60 |
0.46 |
0.44 |
| Thioridazin |
9.85 ± 0.10 |
98.50 |
0.98 |
0.92 |
| 19.66 ± 0.15 |
98.30 |
0.87 |
0.32 |
| 29.60 ± 0.10 |
98.67 |
0.72 |
0.61 |
| Fenactil |
9.65 ± 0.20 |
96.50 |
1.56 |
1.24 |
| 19.56 ± 0.22 |
97.80 |
0.94 |
1.04 |
| 29.65 ± 0.32 |
98.83 |
0.94 |
0.99 |
Where: µ - Confidence limit, p=95%; RSD - relative standard deviation. |
